• Impact Of Changes In The Methodology Of External Price Referencing On Prices

    Nov 1, 2016, 00:00

  • ‘Severe Illness Insurance' in China- Impact of the New Coverage on Access to Health Care and Innovative Drugs

    Nov 1, 2016, 00:00

  • Increased Clinical and Economic Benefit in Spain Associated with Improvement to ±8.5% of The Accuracy of Glucose Meters Adapted to The Current ISO 15197-2013 (±15%)

    Nov 1, 2016, 00:00

  • Analysis of Affordability and Consumption of Statins in Ukraine in 2015

    Nov 1, 2016, 00:00

  • Evaluating Patient Access to Targeted Therapeutics Amidst the Evolving Singaporean Health Care Landscape

    Nov 1, 2016, 00:00

  • Severe Sepsis In Adults- Impact of Diagnostic Coding on Hospital Resource Utilization

    Nov 1, 2016, 00:00

  • A Qualitative Study to Explore The Experiences of Lung Cancer Patients About Disease and its Prevention

    Nov 1, 2016, 00:00

  • A Systematic Review Of The Cost-Effectiveness Of Quadrivalent Influenza Vaccine

    Nov 1, 2016, 00:00

  • Treatment Outcomes Following Initiation of Dapagliflozin or Basal Supported Oral Therapy Among Type 2 Diabetes Patients In Primary Care Practices In Germany

    Nov 1, 2016, 00:00

  • Increased Use of Effective Non-Cancer Drugs Following Removal of Benefit Caps Among Cancer Patients In Medicaid- A Quasi-Experimental Study

    Nov 1, 2016, 00:00

  • Using Best-Worst Scaling Choice Experiments to Elicit the Most Important Domains of Health-Related Quality of Life (HRQOL) in Singapore

    Nov 1, 2016, 00:00

  • Epidemiological Profiling of Chronic Headache Patients At A Public Tertiary Care Setting in India

    Nov 1, 2016, 00:00

  • Efficacy and Safety Profile of Lenvatinib and Sorafenib in The Treatment of Adult Patients with Advanced Radioactive-Iodine-Refractory Differentiated Thyroid Cancer (RR-DTC)

    Nov 1, 2016, 00:00

  • Economic Evaluation of Diacerein, Diclofenac and Glucosamine for Osteoarthritis in China

    Nov 1, 2016, 00:00

  • A Review of the Cost of Medication Nonadherence in Type 2 Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Clinical And Economic Outcomes Of Patients Hospitalized For Herpes Zoster In Hong Kong

    Nov 1, 2016, 00:00

  • A Review Of Patient-Reported Outcome Measures To Assess Infertility-Related Quality Of Life

    Nov 1, 2016, 00:00

  • Health Technology Assessment of the use Vaccines for Prevention Flu

    Nov 1, 2016, 00:00

  • Effect of Smoking Status on Costs-of-Illness in Patients with a Depressive Disorder in Spain- An Approximation from the National Health Survey

    Nov 1, 2016, 00:00

  • Psychometric Properties Of The Finnish Version Of The Locomotor Capabilities Index-5

    Nov 1, 2016, 00:00

  • Teledermoscopy as a Referral Method in Australia- A Decision Analytic Model

    Nov 1, 2016, 00:00

  • How is Radiotherapy Reimbursed Across Europe? Results of The Health Economics in Radiation Oncology’s Survey

    Nov 1, 2016, 00:00

  • Comparison of Mirena Intrauterine Device with Oral Progesterone Treatment and Surgical Treatment in Idiopathic Menorrhagia Patients- Results of A Cost-Minimisation Analysis

    Nov 1, 2016, 00:00

  • Evaluating The Economic Impact Of Potentially Inappropriate Prescribing In Older People In Ireland Using A Markov Modelling Approach

    Nov 1, 2016, 00:00

  • Societal Impact of One-Time Screening for Diabetes at Age 30 in the Indian Population- A Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • A Time Series Analysis of Social Insurance and Patient Costs of Reimbursed Medical AIDS in Hungary

    Nov 1, 2016, 00:00

  • To What Extent Does the Published Economic Analyses of Treatments for Opioid Use Disorder Capture its Chronic, Relapsing Nature and its Impact on Society?

    Nov 1, 2016, 00:00

  • Improving Medication Adherence Through Calendar Packaging- Results of A Randomized Controlled Trial among Hypertensive Patients in Malaysia

    Nov 1, 2016, 00:00

  • Data Imputation for Missing Values in a Claim-Based Administrative Database- Comparison of Imputatation Approaches

    Nov 1, 2016, 00:00

  • HBSAG Seroclearance after Treatment-Induced HBEAG Seroclearance in Chronic Hepatitis B Patients in Beijing, China

    Nov 1, 2016, 00:00

  • Understanding Continuity of Care at a Provider and Practice Level

    Nov 1, 2016, 00:00

  • Heart Rate Recovery in Inflammatory Bowel Disease (Ibd)

    Nov 1, 2016, 00:00

  • Market Access In The Context Of Economic Crisis- Insights From Several European Countries

    Nov 1, 2016, 00:00

  • Impact of The International Reference Pricing on Access To Standard Therapy Drugs for Asthma and Copd

    Nov 1, 2016, 00:00

  • Outcomes Prediction Using a Generalized Linear Model in a Cohort of Schizophrenic Patients Receiving Paliperidone Long Acting Injectable Treatment in Hong Kong

    Nov 1, 2016, 00:00

  • Study On Medication Adherence Behavior And Quality Of Life In Elderly Diabetc, Hypertension Patients In A Tertiary Care Hospital; A Prospective Study

    Nov 1, 2016, 00:00

  • The Impact of Different Gastrointestinal Symptoms on The Well-Being of Affected Patients - Utility Weights for The Gastrointestinal Symptom Score (GIS)

    Nov 1, 2016, 00:00

  • Health State Utilities for Persistent, Recurrent or Metastatic Cervical Cancer in France

    Nov 1, 2016, 00:00

  • Burden of Cancers Attributable to Tobacco Smoking in Member Countries of the Association of South East Asian Nations (Asean), 2012

    Nov 1, 2016, 00:00

  • The Comparative Pharmacoeconomic Analysis of Using Different Reperfusion Strategies for Patients with St Segment Elevation Myocardial Infarction (STEMI)

    Nov 1, 2016, 00:00

  • Cost Analysis of Human Genome Sequencing in Cancer Diagnosis in Fran Next Generation Sequencing

    Nov 1, 2016, 00:00

  • Value of Improved Accuracy for Self-Monitoring of Blood Glucose Devices in Germany

    Nov 1, 2016, 00:00

  • Pediatric Registry Of Patients With Severe Persistent Uncontrolled Asthma Receiving Omalizumab

    Nov 1, 2016, 00:00

  • Health Technology Assessment (HTA) for Orphan Drugs in Cost-Effectiveness (CE) Markets- Current Development and Future Trends

    Nov 1, 2016, 00:00

  • Developing a Geospatial Web and Mobile Application to Improve Expanded Program on Immunization in Ghana- A Mhealth Technology Novelty, 2015

    Nov 1, 2016, 00:00

  • Budget Impact Of Ulipristal Acetate 5mg In Pre-Operative Treatment Of Uterine Fibroids- An Analysis Based On Public Data On Hospital Stays In France

    Nov 1, 2016, 00:00

  • Type 2 Diabetes in Turkey – A Cost of Illness Study

    Nov 1, 2016, 00:00

  • The Impacts of Case Payment in Rural Hainan of China

    Nov 1, 2016, 00:00

  • Impact Of Post-Inscription Studies On Reassessment In Fran A Case Study On Orphan Drugs

    Nov 1, 2016, 00:00

  • Translation And Validation Of Condition-Specific Quality Of Life Pfdi-20 And Pfiq-7 Questionnaires For Women With Pelvic Floor Dysfunction In The Norwegian Context

    Nov 1, 2016, 00:00

  • Pharmacotherapies for the Treatment of Behavioral and Psychological Symptoms of Dementia - A Systematic Review On Recent Evidence

    Nov 1, 2016, 00:00

  • DRG Appropriateness Analysis Using Activity-Based-Costing Method – A Case of Burn Diagnosis

    Nov 1, 2016, 00:00

  • Assessment of Secondary Recurrence of Stroke in Aspirin-Clopidogrel Combination Therapy and Aspirin Monotherapy in Transient Ischemic Attack Patients in South India- A Comparative Study

    Nov 1, 2016, 00:00

  • Virtual Planning and Patient-Specific Implants in Mandibular Reconstructionsurgery- A Micro-Costing Analysiss

    Nov 1, 2016, 00:00

  • Applying A Simulation Model to Manage Waiting Lists For Hospital Inpatient Activity in AN EU Region

    Nov 1, 2016, 00:00

  • Risk of Motor-Vehicle Accidents Increases with Multimorbidity

    Nov 1, 2016, 00:00

  • The Follow-Up and Utilization of Drug Treatment for Chronic Hbv/Hcv Patients with Major Psychiatric Diseases in Taiwan

    Nov 1, 2016, 00:00

  • Preliminary Cost-Effectiveness Assessment of 3D Printed Anatomic Models for Congenital Heart Diseases

    Nov 1, 2016, 00:00

  • Network Meta-Analysis Across Longitudinal Time Points- A Comparison of Available Methods

    Nov 1, 2016, 00:00

  • Real-World Quality-Adjusted Life-Years Gains In Portuguese Patients with Rheumatoid Arthritis Following 1 Year of Golimumab Treatment

    Nov 1, 2016, 00:00

  • Cost Of Total Parenteral Nutrition Services At Ministery Of Health In Saudi Arabia

    Nov 1, 2016, 00:00

  • The 2012 Updated Beers Criteria in Falls Related Hospitalization in Older Adults

    Nov 1, 2016, 00:00

  • Oral And General Health Related Quality of Life In Times of Crisis In Greece

    Nov 1, 2016, 00:00

  • Analysis Of Real Data For Treatment Of Nausea And Vomiting Of Pregnancy (Nvp) In Ukraine

    Nov 1, 2016, 00:00

  • Comparative Exploratory Analysis on Effectiveness, Tolerability And Patient/Nurse Satisfaction With Two Non-Invasive Patient Controlled Analgesia Treatments For Acute Post-Operative Pain Management

    Nov 1, 2016, 00:00

  • Measures Taken By The Romanian Ministry Of Health For Better Access To Anti-Egfr Drugs

    Nov 1, 2016, 00:00

  • ORphan Drug Market Analysis In Turkey

    Nov 1, 2016, 00:00

  • Adoption of Innovative Technologies and Substitution Effects- Computed Tomographic Coronary Angiography In Australia

    Nov 1, 2016, 00:00

  • Choosing First-Line Treatment of Metastatic Colorectal Cancer Based on Biomarker Ras Status- A Budget Impact Analysis From Brazilian Health Insurance System Perspective

    Nov 1, 2016, 00:00

  • Patient Reported Outcomes - Patient Satisfaction With Selected Characteristics of Rehabilitation Medical Devices - Usage, Acquisition, offer, Range And Quality

    Nov 1, 2016, 00:00

  • The Economic Burden of Atrial Fibrillation in Latin America

    Nov 1, 2016, 00:00

  • Efficacy of The Fixed Combination of Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam Vs Traditional Topical Treatment In Psoriasis- A Bayesian Network Meta-Analysis

    Nov 1, 2016, 00:00

  • Hospital Resource Utlization of Patients Over 40 Years old with Chronic Obstructive Pulmonary Disease in South Korea

    Nov 1, 2016, 00:00

  • The mothif study. Costs of Clotting Factors In Haemophilia A And B- A Review From The Berhlingo Database In Seven Comprehensive Health Care Centres In France

    Nov 1, 2016, 00:00

  • Value Added Medicines- What Value Repurposed Medicines Might Bring To Society?

    Nov 1, 2016, 00:00

  • Health Outcomes Assessment and Treatment Regimens For Patients with Gastric Cancer in Shanghai China

    Nov 1, 2016, 00:00

  • The value of timely implementation in hiv/sti testing- cost-effectiveness vs. Speed of intervention rollout

    Nov 1, 2016, 00:00

  • Aligned and Flexible? A Comparative Review of SMC and Nice Decision-Making

    Nov 1, 2016, 00:00

  • Effectiveness Of Self-Monitoring Of Blood Glucose (Smbg) In Reducing Hba1c Of Diabetes Mellitus Type-2 Patients In Jakarta, Indonesia- Preliminary Findings

    Nov 1, 2016, 00:00

  • Translation of the UK Paediatric Influenza Primary School Vaccination Programme to 13 European Countries Using a Dynamic Transmission Model

    Nov 1, 2016, 00:00

  • The Mosaic Study- Regional Variation in Treatment Patterns Associated with Progression from Initial Insulin Regimen

    Nov 1, 2016, 00:00

  • Viability Of Using Electronic Medical Records From European Countries As Data In Novelty (A Novel Observational Longitudinal Study Of Patients With Asthma And/Or Copd)

    Nov 1, 2016, 00:00

  • Burden of Medically Attended Acute Gastroenteritis in England- A Cohort Study in CPRD

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Serum Free Light Chain Assay (FREELITE®) for The Diagnosis of Monoclonal Gammopathy in The Brazilian Public and Private Healthcare Systems

    Nov 1, 2016, 00:00

  • Cost Study of Respiratory System Diseases

    Nov 1, 2016, 00:00

  • The Normal Reimbursement Procedure Of The Pharmaceutical Submissions Between 2013 And 2015 In Hungary - Needs And Results

    Nov 1, 2016, 00:00

  • Real-World Treatment Patterns and Outcomes for Patients with Advanced Soft Tissue Sarcoma Receiving Systemic Therapy in The United Kingdom

    Nov 1, 2016, 00:00

  • Patient Group Submissions (PGSS) in Health Technology Assessment (HTA) In Scotland- Prevalence And Impact

    Nov 1, 2016, 00:00

  • Innovative Therapies for The Treatment of Cancer- An Overview of Late-Phase Clinical Development

    Nov 1, 2016, 00:00

  • How to Handle Data Quality Issues in EQ-5D-5L Valuation Studies. The Spanish Case

    Nov 1, 2016, 00:00

  • Indicators in Evaluating Financial and Economic Performance of Pharmacy- A Systematic Review

    Nov 1, 2016, 00:00

  • Analysis of the Costs Associated with the Management of Adverse Events Compared Through Tkis in the Treatment of Patients with Non-Small Cells Lung Cancer EGFR Mutated

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of the Pharmacist-Assisted Warfarin Monitoring Program (PAWM) at a Medical Center in Taiwan

    Nov 1, 2016, 00:00

  • Impact of Glucosamine on the Burden of Knee Osteoarthritis Over A 6 Month-Period in Fran An Observational Study

    Nov 1, 2016, 00:00

  • The Importance of Model Conceptualisation- A Case Study in Ankylosing Spondylitis (AS) and Non-Radiographic Axial Spondyloarthritis (NR-AXSPA)

    Nov 1, 2016, 00:00

  • Systematic Review of Health State Utilities in Children with Asthma

    Nov 1, 2016, 00:00

  • Impact of National Criteria and Healthcare System Characteristics on Access to Biologic Dmards in Rheumatoid Arthritis In Europe

    Nov 1, 2016, 00:00

  • Current Trends in Methods of Pharmacoeconomic Studies of Cancer Therapies in China

    Nov 1, 2016, 00:00

  • Comparing The Safety Profiles Of Biosimilars With Their Originators’- A Cross Sectional Analysis On The Eu-Rmp

    Nov 1, 2016, 00:00

  • A Cost-Utility Analysis of Dabigatran, Enoxaparin, and Usual Care for Venous Thromboprophylaxis after Hip or Knee Replacement Surgery in Thailand

    Nov 1, 2016, 00:00

  • Health-Related Quality of Life in Opioid use Disorder Measured by Utilities- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Change Management of Polypharmacy and Adheren The Experience of Eu Simpathy Program

    Nov 1, 2016, 00:00

  • Real World Data in Health Technology Assessments –Use of Routinely Collected Data to Address Epidemiologic Questions in Kidney Transplantation in the Amnog Process in Germany

    Nov 1, 2016, 00:00

  • The Dynamic Evolution of External Price Referencing Implementation in Various Countries

    Nov 1, 2016, 00:00

  • Systematic Literature Review and Assessment of the Reporting Quality of Economic Evaluation Studies in Non-Small Cell Lung Cancer in China

    Nov 1, 2016, 00:00

  • Efficiency in Use of Lensx Vs Phacoemulsification Surgery for Cataract Treatment- Results from a Global Observational Study

    Nov 1, 2016, 00:00

  • Association of Patient-Reported Anxiety and Depression with Clinical Measurements, Disability, and Treatment Satisfaction Among Patients with Rheumatoid Arthritis

    Nov 1, 2016, 00:00

  • Effect of Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Statins on Sepsis-Related Outcomes

    Nov 1, 2016, 00:00

  • Barriers Influencing Implementation of Guidelines Into Clinical Practice in Czech Republic

    Nov 1, 2016, 00:00

  • The Impact of Cancer Prevention and Treatment Policy on Increasing Incidence of Early-Stage Cancer in Taiwan

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Screening for and Managing Identified Hypertension for Cardiovascular Disease Prevention in Vietnam

    Nov 1, 2016, 00:00

  • Weakness of Registration Bioequivalent Drugs

    Nov 1, 2016, 00:00

  • Factors Affecting Prolonged Length of Stay In Patents With Mood Disorders

    Nov 1, 2016, 00:00

  • Quality of Life (QOL) and Health Utility (UT) in Patients with Type 2 Diabetes Mellitus (DM2) Receiving Different Oral Hypoglycemic Therapy in a Real-World Setting

    Nov 1, 2016, 00:00

  • Economic Evaluation Of Abbvie’s Regimen (Viekirax/Exviera) For Patients With Genotype 1a Hcv In Greece

    Nov 1, 2016, 00:00

  • Cost-Utility of Unicompartmental Compared To Total Knee Replacements- An Analysis Based on Matched Routinely-Collected Data From The United Kingdom

    Nov 1, 2016, 00:00

  • Differentiation Of Health Related Quality Of Life Outcomes Between Patient Populations; Results From Patients With Breast Cancer, Rheumatoid Arthritis, Multiple Sclerosis, Rare Cancers And Rare Diseases

    Nov 1, 2016, 00:00

  • Analysing The Evolution of Cancer Drug Prices in France Since 2000

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Aspects of Different Inhibitors of Tyrosine Kinase in First-Line Therapy of Patients with Advanced Non-Small Cell Lung Cancer with A Mutation in Epidermal Growth Factor Receptor (EGFR) Gene

    Nov 1, 2016, 00:00

  • How Does Pricing and Access of Innovative Oncology Agents in China Compare with Other Asian Markets?

    Nov 1, 2016, 00:00

  • The Economic Burden of Schizophrenia in Malaysia

    Nov 1, 2016, 00:00

  • Costs of HPV-Related Cancers in The Netherlands

    Nov 1, 2016, 00:00

  • What is an Efficient and Affordable Trastuzumab Therapy in a Middle-Income Country? - Adjuvant Therapy with Trastuzumab in Management of Early HER2-Positive Breast Cancer in Iran

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Bariatric Surgery Compared With Non-Surgical Treatment of Morbid Obesity In Poland

    Nov 1, 2016, 00:00

  • Diffusion of Trans-Arterial Radioembolization for The Treatment of Intermediate-Advanced Hepatocellular Carcinoma in Italy- A Budget Impact Analysis

    Nov 1, 2016, 00:00

  • Estimating The Impact Associated To The Use Omalizumab In The Treatment of Severe Persistent Allergic Asthma In Portugal – Evaluating Outcomes And Treatment Costs Using Real World Data From Portuguese Patients

    Nov 1, 2016, 00:00

  • Identifying The Unmet Medical Need of Angelman Syndrome- Results of A Targeted Literature Review

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Everolimus for Patients with Advanced Neuroendocrine Tumors of the Gastrointestinal (GI) or Lung Origin -A Canadian Societal Health Care System Perspective

    Nov 1, 2016, 00:00

  • Impact of Adoption of A New Drug on the Trends in Utilization Patterns Changes and Pharmaceutical Expenditure- An Example of Urate-Lowering Therapy

    Nov 1, 2016, 00:00

  • Mapping The Policy Response To Breast Cancer In Asia

    Nov 1, 2016, 00:00

  • Review of Clinical Practice Guidelines and Treatment Patterns in Metastatic Pancreatic Cancer in EU-5 Countries

    Nov 1, 2016, 00:00

  • Drug Utilization Evaluation of Antibiotics in General Medicine Department of a Tertiary Care Hospital

    Nov 1, 2016, 00:00

  • The Pareto Principle ("80−20 Rule") In Healthcare Services In Greece

    Nov 1, 2016, 00:00

  • Extended Half-Life Coagulation Factor IX In Haemophilia B Prophylaxis- A Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • Economic Burden of Gefitinib Versus Pemetrexed for Insured Patients with Lung Cancer in Urban Xinjiang Province, China- A Real World Research

    Nov 1, 2016, 00:00

  • Benefits of An Automatic Tool For Glucose Pattern Detection

    Nov 1, 2016, 00:00

  • The Cost Of Multiple Sclerosis In 16 European Countries- Functional Status, Symptoms And Mental Factors Drive Costs

    Nov 1, 2016, 00:00

  • A Systematic Review and Network Meta-Analysis of Intravitreal Aflibercept Injection Versus other Treatments For Macular Edema Secondary to Central Retinal Vein Occlusion

    Nov 1, 2016, 00:00

  • Treatment of Upper-Extremity Sarcoma with Limb-Salvage Procedures Showed Good Functional Outcomes- A Pilot Study Of 13 Consecutive Patients

    Nov 1, 2016, 00:00

  • A Systematic Review- Economic Burden Of Needlestick Injuries On Healthcare Workers

    Nov 1, 2016, 00:00

  • The Impact of Atrial Fibrillation on the Economic Burden of Ischemic Stroke Patients in Beijing

    Nov 1, 2016, 00:00

  • Reconsidering Drugs Funded Via The Cancer Drugs Fund in England- What’s New This Time?

    Nov 1, 2016, 00:00

  • Use of Health Economic Information in the Management of Health Care Resource Allocation

    Nov 1, 2016, 00:00

  • Comparing Coronary Artery Disease Treatment Outcomes – An Example Based on Health-Related Quality of Life Measurements

    Nov 1, 2016, 00:00

  • A Simulation Model for Peripheral Arterial Disease- Methods and Application of A Markov Model

    Nov 1, 2016, 00:00

  • A Trial-Based Euroqol Eq-5d Health Utility Analysis in Patients with Previously Treated Advanced Nsclc

    Nov 1, 2016, 00:00

  • Analysis of Two Pressure Ulcer Dressings for Cost Reduction In The Brazilian Public Health System

    Nov 1, 2016, 00:00

  • Combination Oncologics- A Boon or Burden to Healthcare Systems?

    Nov 1, 2016, 00:00

  • The Utilization Of Selected Screening Tests In Gree A Descriptive Analysis

    Nov 1, 2016, 00:00

  • Eltrombopag Vs Romiplostim In Adult Patients With Chronic Immune Trombocytopenia- Economic Evaluation

    Nov 1, 2016, 00:00

  • Artificial Integligence To Support The Development Of Health Technology Assessment Reports

    Nov 1, 2016, 00:00

  • The Value Of Patient Reported Outcomes In German Amnog Dossiers

    Nov 1, 2016, 00:00

  • A Qualitative Comparison of German and UK Health Technology Assessments- Vedolizumab Case Study

    Nov 1, 2016, 00:00

  • Cost-Benefit Analysis of Dental Prosthesis in Ukraine

    Nov 1, 2016, 00:00

  • Local Utilities for Local Studies- Data Availability and Methodology in Japan and Korea

    Nov 1, 2016, 00:00

  • Financial Analysis of the Final Prices, Co-Paymants and Reimbursment of Antihypertensives in Slovakia from 2008-2014

    Nov 1, 2016, 00:00

  • Pricing and Market Access of Orphan Drugs in China- Analysis of National and Provincial Policy and the Associated Impact on Coverage

    Nov 1, 2016, 00:00

  • Measuring The Influence Of Patient Counseling At Tertiary Care Hospital In Antenatal Care, South Karnataka, India

    Nov 1, 2016, 00:00

  • A Budget Impact Analysis of Alternative Treatment Options for Colorectal Cancer in Greece

    Nov 1, 2016, 00:00

  • The Study of the Effect of Pharmacy Manager's Managerial Skills on the Performance of Community Pharmacies of Tehran

    Nov 1, 2016, 00:00

  • Treatment Patterns, Biomarker Testing (BMX) Practices and Healthcare Resource Use (HCRU) in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) in Taiwan

    Nov 1, 2016, 00:00

  • Association between Copayment, Medication Adherence and Outcomes in the Management of Patients with Diabetes and Heart Failure

    Nov 1, 2016, 00:00

  • Changing Of Prescriptions For Diabetes, Hyperlipidemia, And Hypertension, From Generic Drugs To Protected Brand Drugs - A Retrospective Cohort Study Using A National Inpatient Database In Japan

    Nov 1, 2016, 00:00

  • A Review on the Current Status of Health Economic Modeling in Personalized Medicine

    Nov 1, 2016, 00:00

  • Health Insurance Cost of Stroke in Hungary- A Cost of Illness Study

    Nov 1, 2016, 00:00

  • The Increasing Importance of A Continence Nurse Specialist To Improve Outcomes And Save Costs of Urinary Incontinence Care- An Analysis of Future Policy Scenarios

    Nov 1, 2016, 00:00

  • Evaluation of the Direct Costs of Health Care During the First Year of Life of Babies Born with Microcephaly in the SUS

    Nov 1, 2016, 00:00

  • Widening Engagement with HTA Though open online Learning

    Nov 1, 2016, 00:00

  • Adverse Events in Relaxing Virtual Environments

    Nov 1, 2016, 00:00

  • Multi-Criteria Decision Analysis (MCDA)- Common Tools for Different Needs Supporting Healthcare Decision Making in Spain

    Nov 1, 2016, 00:00

  • A Secure Smartphone Application For Clinical Research On Wound Healing- Nurstrial

    Nov 1, 2016, 00:00

  • The Effect of Necitumumab in Combination with Gemcitabine-Cisplatin on Health-Related Quality of Life (HRQOL) and Tolerability- Squire Trial Patients with Epidermal Growth Factor Receptor (EGFR)-Expressing Squamous NSCLC Tumours

    Nov 1, 2016, 00:00

  • A Cost-effectiveness Analysis of Pharmacokinetic (Pk) Driven Prophylaxis VS. Standard Prophylaxis In Haemophilia A

    Nov 1, 2016, 00:00

  • Proqolid Database- Evolution Of Content, Structure, And Functionalities (2012-2016) - Integration In Eprovide, A New Online Platform Dedicated To Clinical Outcome Assessment (Coa) Research

    Nov 1, 2016, 00:00

  • Study on Age-Related Drug Use Pattern and Assessment of Medication Adherence in Patients with Chronic Respiratory Diseases

    Nov 1, 2016, 00:00

  • Perception Survey on Health Technology Assessment in Turkey- Does Practice Meet with Regulations

    Nov 1, 2016, 00:00

  • Social Return on Investment in Psoriasis

    Nov 1, 2016, 00:00

  • Implications of Price Erosion of Docetaxel After Loss of Exclusivity on Cost-Effectivess

    Nov 1, 2016, 00:00

  • Correctly Capturing Uncertainty in Treatment Effects in Simulation Modeling

    Nov 1, 2016, 00:00

  • Disease Modifying Treatment (Dmt) is Associated with Lower Hazard for Death Among Multiple Sclerosis (Ms) Patients- Survival Analysis Based on 30 Years Incident Ms Cohort

    Nov 1, 2016, 00:00

  • Institute for Clinical and Economic Review (ICER) VS. Health Technology Assessment (HTA) Agencies- The Case of Multiple Myeloma and PCSK9S

    Nov 1, 2016, 00:00

  • Direct Costs Of Epilepsy In Turkey- A Panel Approach

    Nov 1, 2016, 00:00

  • The Evolution Of Patient Access Schemes

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Obinutuzumab And Ibrutinib In Patients With Chronic Lymphocytic Leukemia In Russia

    Nov 1, 2016, 00:00

  • Don't Put Off Until Tomorrow What You Can Do Today- Cost-Effectiveness of Trastuzumab Plus Paclitaxel Combination Therapy and Sequential use of Paclitaxel and Trastuzumab in the Treatment of Metastatic Breast Cancer in Singapore

    Nov 1, 2016, 00:00

  • Cost of Treatment of Actinic Keratosis on the Face/Scalp in Sweden

    Nov 1, 2016, 00:00

  • Systematic Review Of Studies Estimating The Cost-Effectiveness Of Hiv Pre-Exposure Prophylaxis (Prep) In Men Who Have Sex With Men (Msm)

    Nov 1, 2016, 00:00

  • Health-Related Quality of Life in Patients with Rheumatoid Arthritis At Uttaradit Hospital, Thailand

    Nov 1, 2016, 00:00

  • COPD Drugs In Europe - A Comparison of Market Access Decisions In France, Germany, Sweden and UK with The Prismaccess Database

    Nov 1, 2016, 00:00

  • Using Subpopulation Treatment Effect Pattern Plot to Identify More Efficient Resource Allocation Policies

    Nov 1, 2016, 00:00

  • Budget Impact of Secukinumab For Ankylosing Spondylitis In The UK

    Nov 1, 2016, 00:00

  • Health Care Utilization and Economic Burden of Pancreatic Cancer in The Us Medicare Population

    Nov 1, 2016, 00:00

  • Price And Utilization Of New Drugs Under A Single Public Payer System- Evidence From Taiwan

    Nov 1, 2016, 00:00

  • In-Licensing as a Business Strategy for Pharmaceutical Companies- A Framework for the Nigerian Industry

    Nov 1, 2016, 00:00

  • Rapid Health Technology Assessment – Valveless Trocar System for Advanced Laparoscopic / Robotic Surgery

    Nov 1, 2016, 00:00

  • Mapping Transactions from Pharmaceutical Companies to Healthcare Organisations in the EU5

    Nov 1, 2016, 00:00

  • Self-Reported Sleep Quality, Duration And Health-Related Quality Of Life In Older Chinese

    Nov 1, 2016, 00:00

  • The Evaluation Health Education to Elevate Correct Medication Knowledge and Ability in Community

    Nov 1, 2016, 00:00

  • Pivotal Studies of Oncology Drugs Approved in Europe, Which Evidence Based-Medicine?

    Nov 1, 2016, 00:00

  • Economic Burden of Stroke- A Systematic Review on Post-Stroke Care

    Nov 1, 2016, 00:00

  • Cost-Effectivness Analysis of Axitinib In The Treatment of Metastatic Renal Cell Carcinoma – Clinical Data Vs RWE

    Nov 1, 2016, 00:00

  • Impact of National Orphan Drug Policy and Reimbursement Mechanisms Over the Implementation of Managed Entry Agreements in Select Asia-Pacific Countries

    Nov 1, 2016, 00:00

  • To Evaluate the Outcomes of Concomitant Chemoradiotherapy Followed by Extended Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma - A Retrospective Study

    Nov 1, 2016, 00:00

  • The Patient Journey After A Diagnosis of Early/Locally Advanced Breast CA In Greece And Choice of Provider

    Nov 1, 2016, 00:00

  • Bevacizumab in The Treatment of Kras Wild Type Metastatic Colorectal Cancer- An Economic Analysis Based on The Calgb 80405 Trial

    Nov 1, 2016, 00:00

  • Evaluating The Cost-Benefit of A Cognitive Assessment and Training Program Across A Smart City Population in The UK

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Analysis of Pegylated Liposomal Doxorubicin Versus Doxorubicin In Patients with Metastatic Breast Cancer at High Risk of Cardiac Events

    Nov 1, 2016, 00:00

  • Influence of Medical–Economic Analysis on the Categorization of Special Medical Equipment

    Nov 1, 2016, 00:00

  • Review of the Recommendations Made by the National Institute for Health and Care Excellence (NICE) and the Scottish Medicial Consortium (SMC) Relating to Treatments for Rare Diseases

    Nov 1, 2016, 00:00

  • Zinforo (Ceftaroline Fosamil) Versus other Empiric Antibiotics for Moderate-to-Severe Community Acquired Pneumonia (CAP) In Adults- a Network Meta-Analysis

    Nov 1, 2016, 00:00

  • Evaluation of the Number Needed to Vaccinate (NNV) with Gardasil9 in order to Avert 1 Case of Human Papillomavirus (HPV)-Related Anogenital Disease in France

    Nov 1, 2016, 00:00

  • Cost Comparison Of Medical And Surgical Treatments For Medically Intractable Epilepsy

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Tocilizumab Subcutaneouscombotherapy First Line For The Management of Rheumatoid Arthritis In Greece

    Nov 1, 2016, 00:00

  • Is there Evidence of a Difference Between Willingness to Pay and Willingness to Accept Thresholds? A Review of Nice Technology Appraisals

    Nov 1, 2016, 00:00

  • Thresholds for Clinical Importance in EORTC-QLQ-C30- Application in A Sample of Colorectal Cancer Patients

    Nov 1, 2016, 00:00

  • The use of Alhijama as Complimentary Treatment in Hypertension

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Levofloxacin Inhalation Solution Vs. Aztreonam Inhalation Solution And Tobramycin Dry Powder For Inhalation In Cystic Fibrosis Patients In Sweden

    Nov 1, 2016, 00:00

  • Spatial Distribution of the Total Number of Medical Devices in Turkey- A Classification Analysis

    Nov 1, 2016, 00:00

  • Market Access Challenges of Drugs for Chronic Hepatitis C- A Thematic Analysis of Health Technology Assessments

    Nov 1, 2016, 00:00

  • Incidence Cancer Costs Associated with Head And Neck (HN) Cancers- A Nationwide Study From France In 2008-2013 (EPICORL STUDY)

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Introducing Pharmacist-Managed Warfarin Service In The Republic of Serbia

    Nov 1, 2016, 00:00

  • The Adoption of Roles by Primary Care Providers During Implementation of The New Chronic Disease Guidelines in Urban Mongolia- A Qualitative Study

    Nov 1, 2016, 00:00

  • The Impact of Haemophilia Complications on Health-Related Quality of Life for Adults with Severe Haemophilia

    Nov 1, 2016, 00:00

  • Market Regulation May Influence Drug Price Trajectories - A Comparison of Anti Tumor Necrosis Factor Drug Prices In Israel And The USA

    Nov 1, 2016, 00:00

  • Clinical Outcome and Health Care Costs of Blood Stream Infections with Resistant Klebsiella Pneumoniae in Pediatric Patients

    Nov 1, 2016, 00:00

  • Good Cop, Bad Cop; G-BA and Iqwig in Clinical Outcome Evaluations

    Nov 1, 2016, 00:00

  • The Trends of Emergency Care Admissions Focusing on The Population Over 65 Years of Age

    Nov 1, 2016, 00:00

  • Management of Patients with Statin Intoleran Results from a Survey of Clinicians in Six European Countries

    Nov 1, 2016, 00:00

  • Comparison of Economic Evaluation Guidelines Between Japan and other Countries

    Nov 1, 2016, 00:00

  • Are Allocation Preferences In Health Care Consistent With A Particular Definition Of Severity? Results From A Random-Sample Survey Of Norwegians

    Nov 1, 2016, 00:00

  • Adaptive Prediction of Symptoms Return Upon Discontinuation of Omalizumab Treatment in Chronic Spontaneous Urticaria Patients

    Nov 1, 2016, 00:00

  • Automatic Extraction and Classification of Patients’ Smoking Status from Free Text Using Natural Language Processing

    Nov 1, 2016, 00:00

  • Ethical and Technological Evaluation of Security of Connected Objects and Health Applications- How to Move Towards Certification

    Nov 1, 2016, 00:00

  • Assure-Csu- Resource Use and Economic Burden in Patients with Refractory Chronic Spontaneous/Idiopathic Urticaria in Italy

    Nov 1, 2016, 00:00

  • The Prevalence Of Sexual Dysfunctions Among Hungarian Men

    Nov 1, 2016, 00:00

  • Assessment Of Prices Of Essential Medicines For Chronic Diseases Prevalent In The Asia Pacific Region

    Nov 1, 2016, 00:00

  • A Case Study on the Development, Implementation and Outcome of Critical Disease Insurance in Shen Zhen, China

    Nov 1, 2016, 00:00

  • Health Resource Use and Cost Under Pay on Fee and Case-Based Payment in Hospitalized Patients with Chronic Obstructive Pulmonary Disease in China

    Nov 1, 2016, 00:00

  • Switching Patterns from Warfarin to Non-Vitamin K Oral Anticoagulants In Ireland

    Nov 1, 2016, 00:00

  • Literature Review of Studies Evaluating Cost Effectiveness of Prostaglandins and ß-Blockers in Primary Open Angle Glaucoma Patients

    Nov 1, 2016, 00:00

  • Non-Parametric Approach to Estimating Expected Value of Perfect Information- The Usefulness of this Approach to a National HTA Agency

    Nov 1, 2016, 00:00

  • A Patient Level Simulation Model

    Nov 1, 2016, 00:00

  • The Medication Adherence in Schizophrenia Management by Using Second Generation Antipsychotics in Taiwan- A Population Study Based on Nhrid

    Nov 1, 2016, 00:00

  • When Cost Saving Technologies are Not Adopted Despite Evidence and Payer Recommendations – Intraoperative Fluid Management (IOFM) in the UK

    Nov 1, 2016, 00:00

  • Matching Adjusted Indirect Comparison (MAIC) Analysis For Ponatinib Vs Bosutinib In Third-Line Chronic Phase Chronic Myeloid Leukemia (CP-CML)

    Nov 1, 2016, 00:00

  • Inflammatory Back Pain- Impact on Working Hours, and Quality of Life at 12 Months

    Nov 1, 2016, 00:00

  • Health Insurance-Related Aspects Of Home-Based Parenteral Nutrition In Hungary

    Nov 1, 2016, 00:00

  • A Quantitative Analysis of Health Technology Assessment (HTA) Agencies for Attributes Driving Transparency of the Organization- Comparison of Six Asia-Pacific HTA Agencies

    Nov 1, 2016, 00:00

  • Bilirubin and Neurodegenerative Disease Prevention

    Nov 1, 2016, 00:00

  • Perioperative Therapies Reducing Homologous Transfusions During Cardiovascular Surgery- A Network Meta-Analysis of Randomized Controlled Trials

    Nov 1, 2016, 00:00

  • Prevalence and Management of Anemia in Patients of Chronic Kidney Disease at a Tertiary Care Public Teaching Hospital- Evidence from a Cross Sectional Study

    Nov 1, 2016, 00:00

  • Assessment Of Knowledge And Practice Regarding Foot Care Of Diabetes Mellitus Patient In Tertiary Care Hospitals, Quetta, Pakistan

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Rituximab in the Treatment of Diffuse Large B-Cell Non-Hodgkin's Lyphoma Patients (Dlbcl) in China

    Nov 1, 2016, 00:00

  • Cost of Sorafenib for Russian Government Drug Provision Program

    Nov 1, 2016, 00:00

  • Zinforo (Ceftaroline Fosamil) Versus other Empiric Initial IV Antibiotics for Complicated Skin and Soft Tissue Infections (CSSTI)- A Network Meta-Analysis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Insulin Degludec/Insulin Aspart (IDEGASP) Compared with Biphasic Insulin Aspart (BIASP 30) in Patients with Type 2 Diabetes Mellitus from a Mexican Healthcare Perspective

    Nov 1, 2016, 00:00

  • HTA On Role of Chitosan In Hemostasis

    Nov 1, 2016, 00:00

  • The Accuracy of Patient Self Report in Measuring Continuity of Care in Australia

    Nov 1, 2016, 00:00

  • Cardiovascular Diseases- Pharmacotherapy Utilization In Western Europe and CEE

    Nov 1, 2016, 00:00

  • Economic Evaluation of Everolimus as Second-Line Treatment of Metastatic Renal Cell Carcinoma in Greece

    Nov 1, 2016, 00:00

  • The Shift From A Compassionate Drug Use To The Common Market–Access Process- An Inflationary No Man’s Land?

    Nov 1, 2016, 00:00

  • A Cross-National Comparison Of The Effect Of Age And Gender On Health-Related Quality Of Life (Hrql)

    Nov 1, 2016, 00:00

  • Comprehensive Evaluation of Health Care Workers Perceptions and Attitude on Pharmacists Involvement in Ward Round in Three Tertiary Hospitals in South-East Nigeria

    Nov 1, 2016, 00:00

  • Treatment Cost Estimation of Chronic Gastritis Caused by Helicobacter Pylori

    Nov 1, 2016, 00:00

  • Antiviral Activity and Embryonic Toxicity of Moxidectin Against Influenza Virus H9

    Nov 1, 2016, 00:00

  • Drivers in HTA Decision-Making for Cholesterol Lowering PCSK9 Inhibitors

    Nov 1, 2016, 00:00

  • Comparing Preferences Of Patients With Rheumatic Diseases, Of Experienced Rheumatologists, Nurses And Pharmacists Toward The Treatment Of Rheumatic Diseases With Biological Agents- Results From The Cara Study

    Nov 1, 2016, 00:00

  • Real World Data on the Adherance to the National Policy of Integrative and Complementary Practices in the Brazilian Unified Health System - The Acupuncture Case

    Nov 1, 2016, 00:00

  • Is the Integrated Electronic Health Record Cost-Effective for a Cancer Consultation? Results from the E-SI (PREPS-SIPS) Study

    Nov 1, 2016, 00:00

  • The Economic Impact of Tobacco Smoking In The Latin-American Healthcare Systems- A Study Conducted In Seven Countries And Its Extrapolation At The Regional Level

    Nov 1, 2016, 00:00

  • DPP-4 Inhibitors and Cardiovascular Events in Type 2 Diabetic Patients with Chronic Kidney Disease -- A Nationwide Cohort Study

    Nov 1, 2016, 00:00

  • Quantification Of Quality Of Life Differences Due To Common Diseases In The Age Group 50+ In The United Kingdom

    Nov 1, 2016, 00:00

  • Reform of Chinese State-Owned Enterprise-Affiliated Hospital

    Nov 1, 2016, 00:00

  • The Cancer Drugs Fund- The Evolving Assessment Process

    Nov 1, 2016, 00:00

  • Important Methodological Considerations and Strategies for Resolution for Multinational Retrospective Chart Review Studies

    Nov 1, 2016, 00:00

  • A Cost of Illness Study Evaluating The Burden of Wolfram Syndrome In The United Kingdom

    Nov 1, 2016, 00:00

  • Real World Anaplastic Lymphoma Kinase (ALK) Rearrangement Testing Patterns, Treatment Sequences and Survival of ALK-Inhibitor Treated Patients

    Nov 1, 2016, 00:00

  • Making Sense of Clinical Data Reported in Secondary Conditions- The Epidemiology and Clinical Burden of Hyperglycaemia

    Nov 1, 2016, 00:00

  • Effective Use of Short-Term Healthcare By Immigrants In Chile- Linking Evidence To Policy For Universal Coverage

    Nov 1, 2016, 00:00

  • Management of Children's Acute Diarrhea by Community Pharmacies in Five Towns of Ethiopia- Simulated Client Case

    Nov 1, 2016, 00:00

  • A Cost-Effectiveness Analysis of Pasireotide Long-Acting Compared To Continued Use of A First-Line Somatostatin Antagonist For The Treatment of Acromegaly In Sweden

    Nov 1, 2016, 00:00

  • Which Medical Device for Urinary Incontinence Provides Patient The Higher Quality of Life?

    Nov 1, 2016, 00:00

  • Tasks Involved In Platelet Production And Transfusion From The U.S. Hospital Perspective- Two Process Frameworks

    Nov 1, 2016, 00:00

  • Parametric and Non-Parametric Approaches for Predicting Bacterial Resistance

    Nov 1, 2016, 00:00

  • Treatment of Osteochondral Fracture and Medial Patellofemoral Ligament Rupture After Patellar Dislocation

    Nov 1, 2016, 00:00

  • Patient-Reported Need vs. Concern Around Injectable Therapy and Impact on Adheren A Real-World Survey of 5EU/US T2DM Patients

    Nov 1, 2016, 00:00

  • Cost Per Responder of Lixisenatide Versus Rapid-Acting Insulin Intensification Regimens in an Insulin-Exposed Type 2 Diabetes Mellitus (T2DM) Population

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Nivolumab Monotherapy for Metastatic Melanoma Treatment

    Nov 1, 2016, 00:00

  • Investigating Influenza Vaccinations for Risk Groups in Ukraine

    Nov 1, 2016, 00:00

  • The Implications of Parameter Independence in Probabilistic Sensitivity Analysis

    Nov 1, 2016, 00:00

  • Cost Patterns in Patients Treated with Spinal Cord Stimulation Following Spine Surgery—A Register Based Study

    Nov 1, 2016, 00:00

  • High Levels Of Fears Of Patients With Rheumatoid Arthritis Or Axial Spondyloarthritis Are Associated With Gender, Disease Activity, Anxiety And Depression- A Cross-Sectional Study Of 672 Patients

    Nov 1, 2016, 00:00

  • The Evolution of Risk-Sharing Agreements in the Process of Updating the National List of Health Services in Israel

    Nov 1, 2016, 00:00

  • Azacitidine for Treating Acute Myeloid Leukaemia- A Nice Single Technology Appraisal

    Nov 1, 2016, 00:00

  • 19th Euro - FDS Financial Disclosure Statements

    Nov 1, 2016, 00:00

  • Safety Profile of Daclizumab for the Treatment of Relapsing-Remitting Multiple Sclerosis

    Nov 1, 2016, 00:00

  • Retrospective Database Study Describing Patient Characteristics And Resource Use in Swedish Patients Receiving Second Generation Long Acting Injection Antipsychotics

    Nov 1, 2016, 00:00

  • Online Pharmacy Regulation in India- A Cross Sectional Survey on Perceptions of Health Care Students/Professionals

    Nov 1, 2016, 00:00

  • The Longterm Cost Effectiveness of the “Coaching Patients on Achieving Cardiovascular Health” (Coach) Program in Type 2 Diabetes in Tasmania

    Nov 1, 2016, 00:00

  • Health Economics Analyses for Medical Devices in Asia- A Literature Review

    Nov 1, 2016, 00:00

  • Evaluation of Health Care Costs and Utilization Patterns for Patients with Gout in Taiwan

    Nov 1, 2016, 00:00

  • Disease Activity, Quality of Life And Indirect Costs Associated With Ulcerative Colitis In Poland

    Nov 1, 2016, 00:00

  • Missing the Value of Herd Immunity in Cost-Effectiveness Analysis. A Systematic Review

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of National Screening Program for Pulmonary Tuberculosis in Korea

    Nov 1, 2016, 00:00

  • Variations in Stakeholder Preferences between Innovative Pricing Agreement Types Across the EU5

    Nov 1, 2016, 00:00

  • Network Analysis Approach To Explore Sponsor Involvement In Clinical Trials

    Nov 1, 2016, 00:00

  • Analysis of Antibiotics’ Use in the Treatment of Tonsillopharyngitis in Children Population of Nis District

    Nov 1, 2016, 00:00

  • A Cost-Utility Analysis of the Risk Model-Guided Antiemetic Prophylaxis Versus Physician's Choice in Patients Receiving Chemotherapy for Early-Stage Breast Cancer- A Net-Benefit Regression Approach

    Nov 1, 2016, 00:00

  • TBO-Filgrastim Patterns of Care by Treatment Site and Setting in The United States, 2014 and 2015

    Nov 1, 2016, 00:00

  • New Legislative Pathway of Turkey for Assessing Reimbursement Applicatons of Medical Devices

    Nov 1, 2016, 00:00

  • Number Needed to Treat and Cost Per Clinically Meaningful Outcome of Enzalutamide and Abiraterone Acetate for The Treatment of Metastatic Castration-Resistant Prostate Cancer That Failed Androgen Deprivation Therapy in Brazil

    Nov 1, 2016, 00:00

  • A Systematic Review Comparing Studies of Cardiovascular Event Utilities by Geographic Region

    Nov 1, 2016, 00:00

  • Clinical Responses and Improvements in Patient-Reported Outcomes are Associated with Increased Productivity in the Workplace and at Home in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol

    Nov 1, 2016, 00:00

  • Seasonal Variations of Outpatient Antibiotic use in Austria

    Nov 1, 2016, 00:00

  • Economic Evaluation of Drug Therapy To Prevent Osteoporotic Fractures In Postmenopausal Women With Osteopenia

    Nov 1, 2016, 00:00

  • Dose Increase Beyond Labelled Dose of Biologic Treatments in Moderate to Severe Psoriasis is Associated with Incremental Pharmacy Costs- A Real-World Study in the UK

    Nov 1, 2016, 00:00

  • GLP-1 Receptor Agonist Treatment-Related Features Important to Type 2 Diabetes Mellitus (T2DM) Patients- A Preference Study in Germany

    Nov 1, 2016, 00:00

  • Health Technology Assessment Decisions for Novel Psoriasis and Psoriatic Arthritis Agents- Results, Rationale, and Trends

    Nov 1, 2016, 00:00

  • Assessment of Adhesion Response To 3D Printed Materials For Ophthalmic Device Development

    Nov 1, 2016, 00:00

  • Effect Of A Multifactorial, Interdisciplinary Intervention On Falls And Fall Rate Of The Older People In The Community

    Nov 1, 2016, 00:00

  • Exploring The Potential Value of Improved Care for Secondary Hyperparathyroidism (SHPT) with A Novel Investigational Calcimimetic Therapy

    Nov 1, 2016, 00:00

  • Linguistic Validation of the Finnish Version of the Body-Q Pro Instrument

    Nov 1, 2016, 00:00

  • How much do the insured citizens know about the personal account of china's urban employees' basic medical insurance and what are their needs? Evidence from guizhou, china

    Nov 1, 2016, 00:00

  • Healthcare Resource Utilisation Associated with Patients Treated with Either Exenatide Once Weekly or Basal Insulin- A Retrospective UK Database Analysis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of D-Dimer in The Diagnosis of Venous Thromboembolism in Colombia

    Nov 1, 2016, 00:00

  • A Synopsis on Opportunities and Challenges of Patient Related Outcome Measures (PROMS) for Patient Benefits

    Nov 1, 2016, 00:00

  • Health State Utility Values (Hsuvs) Measured By The Euroqol 5-Dimensions (Eq-5d) Questionnaire In People Living With Hiv (Plhiv)- A Systematic Literature Review (Slr) Using Rapid Review Methodology

    Nov 1, 2016, 00:00

  • Stroke Treatment Cost Analysis for Consideration on Health Cost Determination Using INA-CBG'S (Indonesia Case Based Groups) in Indonesia National Health Insurance Programme 2014

    Nov 1, 2016, 00:00

  • Course of Therapy, Resource Utilization and Costs for The Treatment of Metastatic Colorectal Cancer in Germany

    Nov 1, 2016, 00:00

  • A Population-Based Cohort of Gaucher Disease Patients Identified Using EHR Data

    Nov 1, 2016, 00:00

  • Decision Uncertainty and Need for Further Research- A Case-Study in Fenestrated Endovascular Aneurysm Repair for Complex Abdominal Aortic Aneurysms

    Nov 1, 2016, 00:00

  • Drug Use Analysis of Patients with Hypertension and Diabetes in Shanghai, China- Based on Drug Bidding Database of Shanghai Medical Instituions

    Nov 1, 2016, 00:00

  • Systematic Review of Eq-5d Based Utility Scores in Leukemias

    Nov 1, 2016, 00:00

  • Social Preferences for Rare Diseases in Spain

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis Of Two Type-A Botulinum Toxins In The Management Of Blepharospasm And Cervical Dystonia In Spain

    Nov 1, 2016, 00:00

  • Increasing the Interpretability of Patient-Reported Outcomes Questionnaire Findings Using A Mixed Methods Design- An Example in A Rare Cardiac Clinical Trial

    Nov 1, 2016, 00:00

  • Burden of Low Vision and Blindness in Chinese Elder Popullation-Data from Field Survey

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Different Cervical Cancer Primary Screening Using Cytology, HPV Or P16/KI-67 Testing Alone Or in Combinations for The Austrian Health Care Context

    Nov 1, 2016, 00:00

  • Measuring Of The Uncertainty In Reimbursement System For Medicinal Products

    Nov 1, 2016, 00:00

  • An Indirect Comparison Between Adalimumab, Baricitinib And Tofacitinib For The Treatment of Rheumatoid Arthritis

    Nov 1, 2016, 00:00

  • Understanding Health Technology Assessment (HTA) Bodies in Major Asia-Pacific (APAC) Markets- Systematic Evaluation in 10 APAC Countries

    Nov 1, 2016, 00:00

  • Use Of Surveillance Databases To Describe Influenza Epidemiology In Europe

    Nov 1, 2016, 00:00

  • Cost of Illness Study In Patients With Myasthenia Gravis Treated With Plasma Exchange Therapy In Belgium

    Nov 1, 2016, 00:00

  • The Prescribing, Inpatient, Outpatient and Social Care Costs Associated with Atrial Fibrillation in Scotland- A Record Linkage Study

    Nov 1, 2016, 00:00

  • Current Issues and Future Research Priorities for Health Economic Modelling of at Risk Population for Alzheimer’s Disease/Dementia

    Nov 1, 2016, 00:00

  • Patience is a Virtue When Connecting Evidence Networks

    Nov 1, 2016, 00:00

  • Trend in HBA1C Levels Among Primary Care Diabetes Patients Admitted to a Tertiary Hospital in Singapore in 2013

    Nov 1, 2016, 00:00

  • Cost Minimization Of Using Activated Prothrombin Complex Concentrate Versus Recombinant Activated Factor Vii In Patients With A Nd B Hemophilia In Presence Of Inhibitors

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Brivaracetam Versus Other Antiepileptic Drugs Used as Adjunctive Treatment for Focal Seizures in the Uk- A Discrete Event Simulation Model

    Nov 1, 2016, 00:00

  • Determination of Serum Carbamazepine Concentration Using Dried Blood Spot Specimens for Resource Limited Settings

    Nov 1, 2016, 00:00

  • The Burden of Severe Asthma in France

    Nov 1, 2016, 00:00

  • Patient Access to High-Cost and High-Value Specialty Products in China- Review of Decisions From Zhejiang, Neimenggu, Shandong and Jiangxi

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Brentuximab Vedotin in Relapsed or Refractory Hodgkin's Lymphoma Following Autologous Stem Cell Transplant in Taiwan

    Nov 1, 2016, 00:00

  • Levonorgestrel Intrauterine System And Norethisterone For The Treatment of Chronic Abnormal Uterine Bleeding- A Randomized Clinical Comparison In The Patients of Bahawalpur, Pakistan

    Nov 1, 2016, 00:00

  • Health Related Quality of Life In The Deaf British Signing Population

    Nov 1, 2016, 00:00

  • Evaluating The Experiential Quality of Older People's Community Care- A Concept Mapping Approach To Instrument Design

    Nov 1, 2016, 00:00

  • Prediction Of Costs Associated With The Hospital Management Of Hiv Patients In France Using An Advanced Data Mining Approach On The French Medical Information System Database

    Nov 1, 2016, 00:00

  • Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type-2 Diabetes Mellitus in Spain- A Cost-Effectiveness Analysis

    Nov 1, 2016, 00:00

  • Trans-Pacific Partnership Agreement And Its Impact On Accessibility And Affordability Of Medicines- A Meta-Synthesis

    Nov 1, 2016, 00:00

  • Cost Variations of Inpatient, Daycare and Outpatient Hysteroscopy in A Tertiary-Care Hospital in Malaysia

    Nov 1, 2016, 00:00

  • Which Types of Economic Evaluations are Considered by Health Technology Assessment Agencies?

    Nov 1, 2016, 00:00

  • Cost-Effective Analysis Of The Dengue Vaccine In Costa Rica

    Nov 1, 2016, 00:00

  • The Road to Russian Pharmacoeconomics- Understanding the Drivers for Access to High-Value / Orphan Disease Drugs

    Nov 1, 2016, 00:00

  • Evaluation of Social Security Organization'(SSO) Regulations on Physician Prescribing Pattern in Iran in 2014

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Oral Fentanyl Formulations for Breakthrough Cancer Pain Treatment

    Nov 1, 2016, 00:00

  • A Review Evaluating the Validity of Motion-Based Gaming Platforms to Measure Clinical Outcomes in Clinical Research

    Nov 1, 2016, 00:00

  • Early Indicators of Patients with Major Depressive Disorder in Need of Highly Specialized Care- A Systematic Review

    Nov 1, 2016, 00:00

  • Overview on Epidemiological Data For Multiple Myeloma In Austria

    Nov 1, 2016, 00:00

  • Impact of Potential Drug Interactions in Cardiac Patients on Morbidity Risk- An Observational Prospective Approach

    Nov 1, 2016, 00:00

  • Comparative Evaluation of Preliminary Screening Methods for Colorectal Cancer in a Mass Screening Program

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis For Treatment Of Parkinson’s Disease- A Systematic Review

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Pharmacological Interventions For Preventing Migraine In Children And Adolescent- A Systematic Review and Network Meta-Analysis

    Nov 1, 2016, 00:00

  • Patients' Educational Background was Associated with the Validity and Reliability of a Health-Related Quality of Life Questionnaire

    Nov 1, 2016, 00:00

  • An International Patient Survey on Health Related Quality of Life Aspects not Cpatured by EQ-5D-5L

    Nov 1, 2016, 00:00

  • A Budget Impact Analysis to Estimate The Economic Consequences Of Introducing The Combination of Avastin + Tarceva for The Treatment of First Line Epidermal Growth Factor (EGFR) Metastatic Non-Small Cell Lung Cancer (NSCLC)

    Nov 1, 2016, 00:00

  • Effectiveness of Clinical Pharmacist Intervention on Direct Medical Cost in Chronic Obstructive Pulmonary Disorder Patients - A Randomized Controlled Study

    Nov 1, 2016, 00:00

  • Economic Benefits of Cpap Treatment for Obstructive Sleep Apnea in The Elderly

    Nov 1, 2016, 00:00

  • Cost Of Lost Productivity Due To Premature, Suicide-Related Mortality In Poland

    Nov 1, 2016, 00:00

  • Using Evidence Reviews To Develop Focused Systematic Review Questions

    Nov 1, 2016, 00:00

  • Transcatheter Aortic Valve Implantation For Inoperable Severe Aortic Stenosis - A Meta-Analysis

    Nov 1, 2016, 00:00

  • Pharmacotherapy Consultations By Clinical Pharmacists To Improve Quality And Safe Use Of Medicines- An Experience From Tertiary Care Teaching Hospital

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Treatment of Arm Fractures In Elderly Men And Women – A Systematic Review of The Literature

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Active Surveillance of Beta-D-Glucan in Intensive Care Units in Hong Kong

    Nov 1, 2016, 00:00

  • Assessment of Patient Preferences in the Treatment of Relapsing-Remitting Multiple Sclerosis in Public and Private Systems in Latin America

    Nov 1, 2016, 00:00

  • Cost-Minimization Analysis Of Baofukang Versus Langyi In The Treatment Of Vvc

    Nov 1, 2016, 00:00

  • Impact of Obesity on Patient-Reported Outcomes after Total Knee Replacement

    Nov 1, 2016, 00:00

  • Cost-Minimisation Analysis of Sucroferric Oxhydroxide and Sevelamer Carbonate in Patients on Dialysis with Secondary Hyperparathyroidism in Six European Countries

    Nov 1, 2016, 00:00

  • Cost Effectivess Analysis for Combination of Aspirin and Warfarin Versus Warfarin Alone in Patients with Heart Valve Prosthesis

    Nov 1, 2016, 00:00

  • Resource Utilization and Costs of Resected Pancreatic Cancer Patients Receiving Neoadjuvant Treatment- Findings from a Real-World U.S. Population

    Nov 1, 2016, 00:00

  • Derivation and External Validation of an Early Readmission Risk Prediction Model

    Nov 1, 2016, 00:00

  • The American Society of Clinical Oncology (Asco) Net Health Benefit (Nhb) Assessment Tool- Which Implications for Value Assessment of Cancer Therapies?

    Nov 1, 2016, 00:00

  • The Hector Study- Health Economics Study of Codeine And Tramadol Non-Responders – A Sub Population Analysis

    Nov 1, 2016, 00:00

  • Beware the Impact of Discount Rates in the Assessment of HPV Vaccines

    Nov 1, 2016, 00:00

  • Systematic Review and Network Meta-Analysis (Nma) in Reimbursement Submission; What Nice Says Versus what Nice Wants

    Nov 1, 2016, 00:00

  • Antithrombotic Treatment Pattern in Patients with Atrial Fibrillation in Italy Before and After Xaban/Dtis Launch- The Repair Study Cross-Sectional Results

    Nov 1, 2016, 00:00

  • A Study on Drug Utilization and Drug Related Proplems Among Anti-Ulcer Patiend Admitted in Teaching Hospital

    Nov 1, 2016, 00:00

  • A Systematic Review of Tyrosine Kinase Inhibitors as First Line Treatment for Advanced Non Small Cell Lung Cancer

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Treatment for Recurrent Malignant Glioma in Romania

    Nov 1, 2016, 00:00

  • Increasing Efficiency of Pricing and Market Access Decisions By Cross Functional Interactions

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis Of Daclatasvir With Asunaprevir In Treatment Of Chronic Hepatitis C In The Russian Federation

    Nov 1, 2016, 00:00
  • «
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79 (current)
  • 80
  • »